Atlas Trials

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

Clinical trial NCT00875524 · COMPLETED

Trial details

NCT number
NCT00875524
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dengue VirusDengue FeverDengue Hemorrhagic FeverDengue Disease
Start date
2009-03-01
Primary completion
2014-08-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.